KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Shares Issued (2016 - 2025)

Elevance Health (ELV) has disclosed Shares Issued for 17 consecutive years, with $30.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 87.5% to $30.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.0 million, a 76.92% decrease, with the full-year FY2025 number at $51.0 million, down 76.92% from a year prior.
  • Shares Issued was $30.0 million for Q4 2025 at Elevance Health, up from -$2.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $97.0 million in Q1 2024 to a low of -$25.0 million in Q4 2023.
  • A 5-year average of $39.2 million and a median of $38.0 million in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 183.33% in 2023, then surged 164.0% in 2024.
  • Elevance Health's Shares Issued stood at $42.0 million in 2021, then dropped by 28.57% to $30.0 million in 2022, then crashed by 183.33% to -$25.0 million in 2023, then soared by 164.0% to $16.0 million in 2024, then surged by 87.5% to $30.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Shares Issued are $30.0 million (Q4 2025), -$2.0 million (Q2 2025), and $23.0 million (Q1 2025).